BeiGene (ONC) Depreciation And Amortization

Annual D&A

$171.76 M
+$84.09 M+95.91%

December 31, 2024

Summary

Performance

1-Year Change

+95.91%

3-Year Change

+269.72%

5-Year Change

+822.61%

15-Year Change

+3509.96%

ONC Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

91.51%
ONC annual depreciation & amortization is higher than 91.51% of companies in Healthcare sector

High & Low

All-time High

$171.76 M
ONC annual depreciation & amortization is currently at an all-time high

3-Year Low

$46.46 M
ONC annual depreciation & amortization is currently +269.72% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
ONC previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
ONC next annual earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$4.38 B
ONC annual total expenses is $4.38 billion

Annual Operating Expenses

$3.78 B
ONC annual total operating expenses is $3.78 billion

Annual Cost Of Goods Sold

$594.09 M
ONC annual cost of goods sold is $594.09 million

Annual Interest Expense

-
ONC annual interest expense value is unknown

Quarterly D&A

$50.25 M
-$21.05 M-29.52%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+110.95%

3-Year Change

+110.95%

5-Year Change

+110.95%

ONC Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

91.84%
ONC quarterly depreciation & amortization is higher than 91.84% of companies in Healthcare sector

High & Low

All-time High

$71.29 M
ONC quarterly depreciation & amortization is currently -29.52% below its historical high of $71.29 million

3-Year Low

$15.46 M
ONC quarterly depreciation & amortization is currently +224.99% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
ONC previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 8, 2025
ONC next earnings announcement is scheduled for May 8, 2025

Related metrics

Quarterly Total Expenses

$1.21 B
ONC quarterly total expenses is $1.21 billion

Quarterly Operating Expenses

$1.05 B
ONC quarterly total operating expenses is $1.05 billion

Quarterly Cost Of Goods Sold

$160.56 M
ONC quarterly cost of goods sold is $160.56 million

Quarterly Interest Expense

-
ONC quarterly interest expense value is unknown

TTM D&A

$171.76 M
+$26.43 M+18.18%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+95.91%

3-Year Change

+95.91%

5-Year Change

+95.91%

ONC TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

91.37%
ONC TTM depreciation & amortization is higher than 91.37% of companies in Healthcare sector

High & Low

All-time High

$171.76 M
ONC TTM depreciation & amortization is currently at an all-time high

3-Year Low

$53.42 M
ONC TTM depreciation & amortization is currently +221.50% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
ONC previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 8, 2025
ONC next earnings announcement is scheduled for May 8, 2025

Related metrics

Annual Total Expenses

$4.38 B
ONC annual total expenses is $4.38 billion

Annual Operating Expenses

$3.78 B
ONC annual total operating expenses is $3.78 billion

TTM Cost Of Goods Sold

$594.09 M
ONC TTM cost of goods sold is $594.09 million

TTM Interest Expense

-
ONC TTM interest expense value is unknown

ONC Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+95.9%+111.0%+95.9%
3 y3 years+269.7%+111.0%+95.9%
5 y5 years+822.6%+111.0%+95.9%

ONC Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+269.7%-29.5%+225.0%at high+221.5%
5 y5-yearat high+822.6%-29.5%+548.3%at high+648.4%
alltimeall timeat high>+9999.0%-29.5%>+9999.0%at high>+9999.0%

BeiGene Depreciation And Amortization History

DateAnnualQuarterlyTTM
Dec 2024
$171.76 M(+95.9%)
$50.25 M(-29.5%)
$171.76 M(+18.2%)
Sep 2024
-
$71.29 M(+186.0%)
$145.34 M(+52.1%)
Jun 2024
-
$24.93 M(-1.4%)
$95.55 M(+2.8%)
Mar 2024
-
$25.29 M(+6.2%)
$92.96 M(+6.0%)
Dec 2023
$87.67 M(+32.3%)
$23.82 M(+10.7%)
$87.67 M(+7.1%)
Sep 2023
-
$21.51 M(-3.7%)
$81.87 M(+6.9%)
Jun 2023
-
$22.34 M(+11.6%)
$76.56 M(+9.9%)
Mar 2023
-
$20.01 M(+11.1%)
$69.69 M(+5.1%)
Dec 2022
$66.28 M(+42.7%)
-
-
Dec 2022
-
$18.02 M(+11.2%)
$66.28 M(+8.0%)
Sep 2022
-
$16.20 M(+4.8%)
$61.38 M(+7.0%)
Jun 2022
-
$15.46 M(-6.9%)
$57.36 M(+7.4%)
Mar 2022
-
$16.60 M(+26.5%)
$53.42 M(+15.0%)
Dec 2021
$46.46 M(+46.1%)
$13.12 M(+7.8%)
$46.46 M(+12.9%)
Sep 2021
-
$12.18 M(+5.6%)
$41.16 M(+10.3%)
Jun 2021
-
$11.53 M(+19.7%)
$37.33 M(+10.9%)
Mar 2021
-
$9.63 M(+23.0%)
$33.67 M(+5.9%)
Dec 2020
$31.79 M(+70.8%)
$7.83 M(-6.2%)
$31.79 M(+1.1%)
Sep 2020
-
$8.34 M(+6.1%)
$31.45 M(+15.9%)
Jun 2020
-
$7.87 M(+1.5%)
$27.12 M(+18.2%)
Mar 2020
-
$7.75 M(+3.6%)
$22.95 M(+23.3%)
DateAnnualQuarterlyTTM
Dec 2019
$18.62 M(+79.2%)
$7.48 M(+86.1%)
$18.62 M(+28.4%)
Sep 2019
-
$4.02 M(+8.8%)
$14.50 M(+12.2%)
Jun 2019
-
$3.69 M(+8.2%)
$12.92 M(+11.8%)
Mar 2019
-
$3.42 M(+1.6%)
$11.56 M(+11.3%)
Dec 2018
$10.39 M(+118.3%)
$3.36 M(+37.5%)
$10.39 M(+14.4%)
Sep 2018
-
$2.44 M(+4.7%)
$9.08 M(+14.4%)
Jun 2018
-
$2.34 M(+4.1%)
$7.93 M(+29.3%)
Mar 2018
-
$2.24 M(+9.3%)
$6.14 M(+29.0%)
Dec 2017
$4.76 M(+149.2%)
$2.05 M(+58.0%)
$4.76 M(+49.8%)
Sep 2017
-
$1.30 M(+140.7%)
$3.18 M(+33.4%)
Jun 2017
-
$540.00 K(-37.5%)
$2.38 M(+2.1%)
Mar 2017
-
$864.00 K(+82.7%)
$2.33 M(+22.3%)
Dec 2016
$1.91 M(+23.6%)
$473.00 K(-6.3%)
$1.91 M(+3.0%)
Sep 2016
-
$505.00 K(+2.6%)
$1.85 M(+5.9%)
Jun 2016
-
$492.00 K(+12.1%)
$1.75 M(+7.3%)
Mar 2016
-
$439.00 K(+5.0%)
$1.63 M(+5.6%)
Dec 2015
$1.54 M(-0.8%)
$418.00 K(+4.0%)
$1.54 M(+37.1%)
Sep 2015
-
$402.00 K(+7.8%)
$1.13 M(+55.4%)
Jun 2015
-
$373.00 K(+6.0%)
$725.00 K(+106.0%)
Mar 2015
-
$352.00 K
$352.00 K
Dec 2014
$1.56 M(-2.2%)
-
-
Dec 2013
$1.59 M
-
-

FAQ

  • What is BeiGene annual depreciation & amortization?
  • What is the all time high annual D&A for BeiGene?
  • What is BeiGene annual D&A year-on-year change?
  • What is BeiGene quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for BeiGene?
  • What is BeiGene quarterly D&A year-on-year change?
  • What is BeiGene TTM depreciation & amortization?
  • What is the all time high TTM D&A for BeiGene?
  • What is BeiGene TTM D&A year-on-year change?

What is BeiGene annual depreciation & amortization?

The current annual D&A of ONC is $171.76 M

What is the all time high annual D&A for BeiGene?

BeiGene all-time high annual depreciation & amortization is $171.76 M

What is BeiGene annual D&A year-on-year change?

Over the past year, ONC annual depreciation & amortization has changed by +$84.09 M (+95.91%)

What is BeiGene quarterly depreciation & amortization?

The current quarterly D&A of ONC is $50.25 M

What is the all time high quarterly D&A for BeiGene?

BeiGene all-time high quarterly depreciation & amortization is $71.29 M

What is BeiGene quarterly D&A year-on-year change?

Over the past year, ONC quarterly depreciation & amortization has changed by +$26.43 M (+110.95%)

What is BeiGene TTM depreciation & amortization?

The current TTM D&A of ONC is $171.76 M

What is the all time high TTM D&A for BeiGene?

BeiGene all-time high TTM depreciation & amortization is $171.76 M

What is BeiGene TTM D&A year-on-year change?

Over the past year, ONC TTM depreciation & amortization has changed by +$84.09 M (+95.91%)